<i>GRIA</i> Gene Expression in Schizophrenia: A Participant-Level Meta-Analysis.
Overview
- School of Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, 6997801 Tel Aviv, Israel
- Department of Physics of Complex Systems, Weizmann Institute of Science, 7610001 Rehovot, Israel
- Adult Inpatient Ward, Shalvata Mental Health Center, 45100 Hod Hasharon, Israel
Abstract
Background: Schizophrenia is a complex mental disorder with an estimated heritability of 80%, yet its underlying pathophysiology remains poorly understood. Emerging evidence implicates the α-amino-3-hydroxy-5-meth
Methods: We conducted a participant-level meta-analysis of seven postmortem brain sample datasets (n = 295; 151 schizophrenia, 144 controls) and analyzed an independent organoid dataset (n = 16). Expression differences between schizophrenia and control samples were quantified using Hedges' g under a random-effects model, with heterogeneity assessed using the I2 statistic.
Results: Our analysis revealed significant downregulation of all four GRIA genes (GRIA1-4) in postmortem brain tissue from individuals with schizophrenia, with the effect concentrated in a subgroup of patients. No substantial heterogeneity was attributable to differences in brain regions or measurement platforms. Consistent downregulation of GRIA1-3 was observed in patient-derived cerebral organoids, which model early neurodevelopmental stages.
Conclusions: Our findings highlight AMPA receptor dysfunction as a potential contributor to schizophrenia pathophysiology in a subgroup of patients, consistent with the broader role of glutamatergic signaling disruption in this disorder. The convergent evidence from postmortem brain tissue and developmental models underscores the need for further investigation of GRIA genes as potential biomarkers for patient stratification and as therapeutic targets. While further study is needed to understand the functional consequences of our findings, such insights may inform the development of personalized treatment strategies targeting glutamatergic dysfunction in schizophrenia.
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data and to no code of its authors: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Data links
- ncbi.nlm.nih.gov/
geo , NCBI; found in “Availability of Data and Materials”
Availability of Data and Materials
All datasets analyzed in this study were previously published and are publicly accessible through the Gene Expression Omnibus (GEO) database (https://
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 28 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 3 authors, 6 keywords, 83 references.
Cite
This paper
Baumel, A., Yitzhaky, A., & Hertzberg, L. (2026). &
BibTeX
@article{baumel2026lt,
author = {Baumel, Adan and Yitzhaky, Assif and Hertzberg, Libi},
title = {{\&
journal = {Alpha psychiatry},
year = {2026},
month = may,
volume = {27},
number = {3},
pages = {46200},
publisher = {IMR Press},
issn = {2757-8038},
doi = {10.31083/
url = {https://
pmid = {42416198},
pmcid = {PMC13339803}
}
RIS
TY - JOUR
AU - Baumel, Adan
AU - Yitzhaky, Assif
AU - Hertzberg, Libi
TI - &
T2 - Alpha psychiatry
J2 - Alpha Psychiatry
PY - 2026
DA - 2026/
VL - 27
IS - 3
SP - 46200
SN - 2757-8038
PB - IMR Press
DO - 10.31083/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.31083/
"type": "article-journal",
"title": "&
"container-title": "Alpha psychiatry",
"author": [
{
"family": "Baumel",
"given": "Adan"
},
{
"family": "Yitzhaky",
"given": "Assif"
},
{
"family": "Hertzberg",
"given": "Libi"
}
],
"container-title-short":
"volume": "27",
"issue": "3",
"page": "46200",
"DOI": "10.31083/
"PMID": "42416198",
"PMCID": "PMC13339803",
"ISSN": "2757-8038",
"publisher": "IMR Press",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
5,
21
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.3390/genes15050609
- Altered Expression of PDE4 Genes in Schizophrenia: Insights from a Brain and Blood Sample Meta-Analysis and iPSC-Derived Neurons.Journal: GenesIn common: schizophrenia / psychosis, cellular / molecular, 14 references, author Libi Hertzberg
- [2] doi:10.1038/s41380-022-01861-8 [code]
- Glutamatergic dysfunction leads to a hyper-dopaminergic phenotype through deficits in short-term habituation: a mechanism for aberrant salience.Journal: Molecular psychiatryIn common: schizophrenia / psychosis, cellular / molecular, 7 references
- [3] doi:10.1186/s13293-024-00635-x [code]
- The impact of sex on gene expression in the brain of schizophrenic patients: a systematic review and meta-analysis of transcriptomic studies.Journal: Biology of sex differencesIn common: schizophrenia / psychosis, genetics / omics, 5 references
- [4] doi:10.1124/pharmrev.120.000131
- Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.Journal: Pharmacological reviewsIn common: cellular / molecular, 5 references
- [5] doi:10.1038/s41398-023-02677-y
- Molecular mapping of a core transcriptional signature of microglia-specific genes in schizophrenia.Journal: Translational psychiatryIn common: schizophrenia / psychosis, cellular / molecular, 5 references
- [6] doi:10.1038/s41386-023-01614-3
- Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry.Journal: Neuropsychopharmacology : official publication of the American College of NeuropsychopharmacologyIn common: schizophrenia / psychosis, cellular / molecular, 5 references
- [7] doi:10.1186/s13073-023-01203-5
- Morphological and transcriptomic analyses of stem cell-derived cortical neurons reveal mechanisms underlying synaptic dysfunction in schizophrenia.Journal: Genome medicineIn common: schizophrenia / psychosis, histology / microscopy, genetics / omics, 1 other category, 4 references
- [8] doi:10.1038/s41380-025-03279-4 [code]
- GRIN2A null variants confer a high risk for early-onset schizophrenia and other mental disorders and potentially enable precision therapy.Journal: Molecular psychiatryIn common: schizophrenia / psychosis, genetics / omics, 5 references
- [9] doi:10.1523/jneurosci.0645-25.2025
- Altered Molecular Composition of a Specific Subset of Prefrontal Cortical Excitatory Synapses in Schizophrenia.Journal: The Journal of neuroscience : the official journal of the Society for NeuroscienceIn common: schizophrenia / psychosis, cellular / molecular, 4 references
- [10] doi:10.1038/s41467-025-67959-z [code]
- Functional implications of polygenic risk for schizophrenia in human neurons.Journal: Nature communicationsIn common: schizophrenia / psychosis, genetics / omics, cellular / molecular, 4 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
